EARLY TAVR published. Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes, driven by the latter. The study's findings may be limited by factors such as its unavoidable unblinded nature, trial-specific vigilance levels, low-risk patient selection, and use of a single valve type. #TCT2024
https://t.co/W1JsvkgrnT
In patients with a Medina 0.0.1 type bifurcation lesion, #PCI with a 1-stent strategy showed comparable outcomes to that of a 2-stent strategy. https://t.co/CnrVLVtuuG
#JACCINT#CardioTwitter@ovidio_def@mySMC
I'm back from Hot Lines session 4, which was entirely dedicated to intravascular imaging, with ILUMIEN IV, OCTOBER and ICTIVUS. Some results were conflicting, so a meta-analysis from @GreggWStone to summarize the state of the art was helpful. These were my comments. #ESCCongress
🦠 Buona domenica!
Per quelli che "Bulgaria e Romania sono casi isolati".
Relazione tra vaccinazione della popolazione adulta e morti #Covid_19 da giugno a oggi, in 33 paesi europei sufficientemente simili quanto a "vecchiaia" della propria popolazione.
Serve altro?
Horizontal Aorta in Transcatheter Self-Expanding Valves: Insights From the HORSE International Multicentre Registry https://t.co/dHmcFu4BKT
Many thanks to all the co-authors!
Moderate Aortic Stenosis for #TAVR; a step too far? Join us for Journal club as @GalloFrance87 presents the latest study from @JACCJournals with commentary by @AntonioMangieri@fra_giannini1
Date: Fri 11th June
Time: 7.30am
Direct message for Zoom Link
Combined procedure: 2 Mitraclip (1 NTRW and 1 NTR) and LAAO (Amulet 34 mm) in a patient with functional severe symptomatic MR and AF with a very high bleeding risk. Excellent result. Residual MR: 1+/4+; mean G: 2 mmHg
Performed by @FedericoRonco1 and @gianpiero_d@drbarbierato